22,328 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Highland Capital Management LLC

Highland Capital Management LLC acquired a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 22,328 shares of the company's stock, valued at approximately $1,296,000.

A number of other large investors have also bought and sold shares of the stock. Robeco Institutional Asset Management B.V. purchased a new position in Doximity in the 1st quarter worth approximately $6,019,000. Bessemer Group Inc. increased its holdings in Doximity by 214.2% in the 1st quarter. Bessemer Group Inc. now owns 1,398 shares of the company's stock worth $81,000 after acquiring an additional 953 shares in the last quarter. Spire Wealth Management raised its position in shares of Doximity by 73.2% during the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares during the period. Lecap Asset Management Ltd. lifted its position in shares of Doximity by 9.2% in the first quarter. Lecap Asset Management Ltd. now owns 42,506 shares of the company's stock valued at $2,467,000 after acquiring an additional 3,566 shares in the last quarter. Finally, Friedenthal Financial boosted its stake in Doximity by 7.7% in the 1st quarter. Friedenthal Financial now owns 14,857 shares of the company's stock worth $862,000 after purchasing an additional 1,061 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DOCS has been the subject of several recent analyst reports. JPMorgan Chase & Co. dropped their price objective on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a research note on Tuesday, May 27th. The Goldman Sachs Group set a $50.00 target price on Doximity and gave the stock a "neutral" rating in a research note on Wednesday, May 21st. Needham & Company LLC decreased their price target on shares of Doximity from $82.00 to $67.00 and set a "buy" rating for the company in a report on Friday, May 16th. Raymond James Financial cut their price target on shares of Doximity from $83.00 to $65.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Finally, Morgan Stanley decreased their price objective on Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a report on Thursday, April 24th. Eleven research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $63.11.

Doximity Stock Up 0.4%

NASDAQ:DOCS traded up $0.22 during mid-day trading on Monday, reaching $61.31. 1,489,676 shares of the company were exchanged, compared to its average volume of 2,169,634. The stock has a market cap of $11.52 billion, a PE ratio of 61.31, a PEG ratio of 4.10 and a beta of 1.33. The company has a fifty day moving average of $56.21 and a 200 day moving average of $58.83. Doximity, Inc. has a 12 month low of $25.00 and a 12 month high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last released its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same period last year, the business earned $0.25 EPS. The firm's revenue was up 17.1% on a year-over-year basis. On average, equities research analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Insider Activity

In other news, CFO Anna Bryson sold 45,000 shares of the business's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the transaction, the chief financial officer directly owned 357,165 shares of the company's stock, valued at $20,440,552.95. The trade was a 11.19% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the sale, the director directly owned 16,618 shares of the company's stock, valued at approximately $946,062.74. This trade represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 71,000 shares of company stock valued at $4,100,770 in the last three months. Company insiders own 37.40% of the company's stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.